Old Web
English
Sign In
Acemap
>
authorDetail
>
Christopher Ngai
Christopher Ngai
Bayer Corporation
Physical therapy
Colorectal cancer
Medicine
Quality of life
Health care
2
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Economic burden of common adverse events (AEs) associated with metastatic colorectal cancer (mCRC) treatment in the United States (US).
2016
Journal of Clinical Oncology
Dominick Latremouille-Viau
Jane Chang
Annie Guerin
Sherry Shi
Ed Wang
Justin Yu
Christopher Ngai
Show All
Source
Cite
Save
Citations (0)
Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial:
2015
Journal of Clinical Oncology
Jane Chang
Christopher Ngai
Dawn Odom
Christina Radder
Christian Kappeler
Rui Hua Xu
Shukui Qin
Tae-Won Kim
Jin Li
Show All
Source
Cite
Save
Citations (2)
1